Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/16 → 12/1/21 |
Funding
- PPD Development (Prot# SHP621-302 // Prot# SHP621-302)
- Shire Human Genetic Therapies, Inc. (Prot# SHP621-302 // Prot# SHP621-302)
Prot# SHP621-302: A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) with E
- Hirano, Ikuo (PD/PI)
Project: Research project